| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $843.3M | $951.6M | $1.07B |
| YoY Revenue Growth % | -11.4% | -11.2% | — |
| Gross Profit | — | — | — |
| Gross Margin % | — | — | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | $345.4M | $455.2M | $615.4M |
| Operating Margin % | 41.0% | 47.8% | 57.4% |
| Net Income (GAAP) | $309.3M | $416.7M | $556.5M |
| EBITDA (Normalized) | $375.7M | $489.5M | $654.0M |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | $380.1M | $547.1M | $688.4M |
| Capital Expenditures (CapEx) | $37.9M | $42.8M | $48.2M |
| Free Cash Flow (FCF) | $342.1M | $504.3M | $640.2M |
| FCF Margin % | 40.6% | 53.0% | 59.7% |
| Return on Invested Capital (ROIC %) | 11.2% | 15.4% | 25.2% |
| Cash & Short-Term Equivalents | $116.9M | $157.5M | — |
| Total Debt (Short + Long Term) | $541.3M | $638.4M | $747.9M |
| Total Stockholders' Equity | $2.02B | $1.86B | $1.53B |